Periorbital necrobiotic xanthogranuloma resolved with three years of systemic lenalidomide treatment
This case contributes to the existing literature by documenting complete resolution of NXG after three years of lenalidomide treatment, which is a much longer treatment duration than typically described in the literature. These observations alert treating physicians that a longer treatment interval may be needed to address NXG.
Authors
- Kaila Buckley (ORCID: https://orcid.org/0000-0001-8636-6123)
- Jill A. Foster
- Llwyatt K. Hofer
Institutions
- Nationwide Children's Hospital (US)
- Society of Thoracic Surgeons (US)
- Columbus Oncology and Hematology Associates (US)
- The Ohio State University (US)
Publication Details
- Journal
- American Journal of Ophthalmology Case Reports
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1016/j.ajoc.2024.102233
- Primary Topic
- Histiocytic Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00